filmov
tv
COG-UK Showcase Event December 2020
Показать описание
At 2pm on the 16th December 2020, the COVID-19 Genomics UK (COG-UK) consortium presented its first ‘Showcase Event’: SARS-CoV-2 sequencing to inform clinical care, public health interventions and policy decisions. Watch the recording of the event here, the agenda is below.
0:00 – 2:30 Professor Sharon Peacock, Executive Director and Chair, COG-UK
2:31 – 5:18 Sir Patrick Vallance, UK Government Chief Scientific Advisor
5:19 – 7:35 Session 1 introduction: Overview of lineage introduction and transmission. Chair: Dr Rob Orford, Chief Scientific Adviser for Health, Welsh Government
7:36 – 19:02 Scotland. Professor Matt Holden, University of St Andrews and Public Health Scotland
19:03 – 29:46 Wales. Professor Tom Connor, Cardiff University and Public Health Wales
29:47 – 42:18 Northern Ireland. Dr Derek Fairley, Belfast Health and Social Care Trust
42:19 – 50:39 Session summary and Implications for policy and practice. Professor Deenan Pillay, University College London
50:40 – 1:04:02 Questions and break
1:04:03 – 1:08:19 Session 2 introduction: Overview of Genomic-Informed Evidence on Transmission in Specific Environments. Chair: Professor David Crossman, Dean & Head of School of Medicine, University of St Andrews
1:08:20 – 1:20:44 Hospitals. Dr Estee Torok, Cambridge University Hospitals NHS Foundation Trust
1:21:26 – 1:29:50 Care homes. Dr Andrew Page, Quadram Institute, Norwich
1:30:32 – 1:43:00 Universities. Dr Ben Warne, University of Cambridge
1:44:00 – 1:57:38 Sentinel surveillance using pillar 2 samples. Dr Jeff Barrett, Wellcome Sanger Institute
1:57:47 – 2:11:04 The HOCI study. Professor Judy Breuer, University College London
2:11:15 – 2:16:49 Session summary and Implications for policy and practice. Professor Gordon Dougan, University of Cambridge
2:16:50 – 2:24:06 Break
2:24:07 – 2:24:35 Session 3 introduction: SARS-CoV-2 Mutations - Implications for Transmission, Disease Severity, Therapeutics and Vaccines. Chair: Dr Andrew Jermy, External Communications Lead, COG-UK
2:24:36 – 2:36:22 Overview: prevalence, tracking and importance. Professor David Robertson, University of Glasgow
2:36:41 – 2:46:50 Epidemiology of SARS-CoV-2 Genetic Variants. Dr Erik Volz, Imperial College London
2:47:09 – 2:58:33 Mutations and clinical consequences. Professor Emma Thomson, University of Glasgow
2:58:44 – 3:15:10 SARS-CoV-2 mutational escape from therapeutic convalescent plasma. Professor Ravi Gupta, University of Cambridge
3:15:48 – 3:25:30 Coordination of mutation data for public health use. Dr Alessandro Carabelli, University of Cambridge
3:25:55 – 3:27:15 Closing remarks from the Director of COG-UK. Professor Sharon Peacock, Executive Director and Chair, COG-UK
0:00 – 2:30 Professor Sharon Peacock, Executive Director and Chair, COG-UK
2:31 – 5:18 Sir Patrick Vallance, UK Government Chief Scientific Advisor
5:19 – 7:35 Session 1 introduction: Overview of lineage introduction and transmission. Chair: Dr Rob Orford, Chief Scientific Adviser for Health, Welsh Government
7:36 – 19:02 Scotland. Professor Matt Holden, University of St Andrews and Public Health Scotland
19:03 – 29:46 Wales. Professor Tom Connor, Cardiff University and Public Health Wales
29:47 – 42:18 Northern Ireland. Dr Derek Fairley, Belfast Health and Social Care Trust
42:19 – 50:39 Session summary and Implications for policy and practice. Professor Deenan Pillay, University College London
50:40 – 1:04:02 Questions and break
1:04:03 – 1:08:19 Session 2 introduction: Overview of Genomic-Informed Evidence on Transmission in Specific Environments. Chair: Professor David Crossman, Dean & Head of School of Medicine, University of St Andrews
1:08:20 – 1:20:44 Hospitals. Dr Estee Torok, Cambridge University Hospitals NHS Foundation Trust
1:21:26 – 1:29:50 Care homes. Dr Andrew Page, Quadram Institute, Norwich
1:30:32 – 1:43:00 Universities. Dr Ben Warne, University of Cambridge
1:44:00 – 1:57:38 Sentinel surveillance using pillar 2 samples. Dr Jeff Barrett, Wellcome Sanger Institute
1:57:47 – 2:11:04 The HOCI study. Professor Judy Breuer, University College London
2:11:15 – 2:16:49 Session summary and Implications for policy and practice. Professor Gordon Dougan, University of Cambridge
2:16:50 – 2:24:06 Break
2:24:07 – 2:24:35 Session 3 introduction: SARS-CoV-2 Mutations - Implications for Transmission, Disease Severity, Therapeutics and Vaccines. Chair: Dr Andrew Jermy, External Communications Lead, COG-UK
2:24:36 – 2:36:22 Overview: prevalence, tracking and importance. Professor David Robertson, University of Glasgow
2:36:41 – 2:46:50 Epidemiology of SARS-CoV-2 Genetic Variants. Dr Erik Volz, Imperial College London
2:47:09 – 2:58:33 Mutations and clinical consequences. Professor Emma Thomson, University of Glasgow
2:58:44 – 3:15:10 SARS-CoV-2 mutational escape from therapeutic convalescent plasma. Professor Ravi Gupta, University of Cambridge
3:15:48 – 3:25:30 Coordination of mutation data for public health use. Dr Alessandro Carabelli, University of Cambridge
3:25:55 – 3:27:15 Closing remarks from the Director of COG-UK. Professor Sharon Peacock, Executive Director and Chair, COG-UK